Medtronic has received FDA 510(k) clearance for the Multi-Lead Trialing Cable for use in the patient screening test for the spinal cord stimulation therapy, according to the report.
The cable has multiple secure lead configurations with up to 16 test electrodes, only one small cable and no extensions. The spinal cord stimulator is implanted during a minimally invasive outpatient procedure to deliver controlled electric pulses through leads to the epidural space.
The physician can adjust the stimulation settings to optimize therapy and pain control for each patient.
Read the Medtronic release on the Multi-Lead Trialing Cable.
Read other coverage on Medtronic:
- Medtronic Partners With Ziehm Imaging in 3D Intraoperative Technology
- Medtronic Receives FDA 510(k) Clearance for Kyphon Xpander II
- Medtronic Launches Vertebral Fixation System
The cable has multiple secure lead configurations with up to 16 test electrodes, only one small cable and no extensions. The spinal cord stimulator is implanted during a minimally invasive outpatient procedure to deliver controlled electric pulses through leads to the epidural space.
The physician can adjust the stimulation settings to optimize therapy and pain control for each patient.
Read the Medtronic release on the Multi-Lead Trialing Cable.
Read other coverage on Medtronic:
- Medtronic Partners With Ziehm Imaging in 3D Intraoperative Technology
- Medtronic Receives FDA 510(k) Clearance for Kyphon Xpander II
- Medtronic Launches Vertebral Fixation System